These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8608454)

  • 21. Elevated gene expression of MMP-1, MMP-10, and TIMP-1 reveal changes of molecules involved in turn-over of extracellular matrix in cyclosporine-induced gingival overgrowth.
    Dannewitz B; Edrich C; Tomakidi P; Kohl A; Gabbert O; Eickholz P; Steinberg T
    Cell Tissue Res; 2006 Sep; 325(3):513-22. PubMed ID: 16670920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
    Fujiwara M; Muragaki Y; Ooshima A
    Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts.
    Li DQ; Meller D; Liu Y; Tseng SC
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):404-10. PubMed ID: 10670469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.
    Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT
    Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
    Tayebjee MH; Karalis I; Nadar SK; Beevers DG; MacFadyen RJ; Lip GY
    Am J Hypertens; 2005 Mar; 18(3):325-9. PubMed ID: 15797648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinases MMP-2, -9 and tissue inhibitors TIMP-1, -2 expression and secretion by primary human osteoblast cells in response to titanium, zirconia, and alumina ceramics.
    Oum'hamed Z; Garnotel R; Josset Y; Trenteseaux C; Laurent-Maquin D
    J Biomed Mater Res A; 2004 Jan; 68(1):114-22. PubMed ID: 14661256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of basic fibroblast factor (bFGF) on MMP-2, TIMP-2, and type-I collagen levels in human lung carcinoma fibroblasts.
    Nakoman C; Resmi H; Ay O; Acikel U; Atabey N; Güner G
    Biochimie; 2005; 87(3-4):343-51. PubMed ID: 15781321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
    Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
    Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
    J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responses of vascular smooth muscle cell to extracellular matrix degradation.
    Tummalapalli CM; Tyagi SC
    J Cell Biochem; 1999 Dec; 75(3):515-27. PubMed ID: 10536373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of collagen structure on matrix trafficking by human fibroblasts.
    Abraham LC; Vorrasi J; Kaplan DL
    J Biomed Mater Res A; 2004 Jul; 70(1):39-48. PubMed ID: 15174107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural characteristics of human atherectomy tissue from coronary and lower extremity arterial stenoses.
    Bauriedel G; Kandolf R; Schluckebier S; Welsch U
    Am J Cardiol; 1996 Mar; 77(7):468-74. PubMed ID: 8629586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increased in vitro motility of human vascular wall myocytes from restenotic lesions of peripheral and coronary vessels].
    Bauriedel G; Windstetter U; Brandl R; Plas E; Kandolf R; Höfling B
    Z Kardiol; 1991 Aug; 80(8):494-9. PubMed ID: 1950071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy.
    O'Brien ER; Alpers CE; Stewart DK; Ferguson M; Tran N; Gordon D; Benditt EP; Hinohara T; Simpson JB; Schwartz SM
    Circ Res; 1993 Aug; 73(2):223-31. PubMed ID: 8101140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.